ÂÜÀòÂÒÂ×

Dr. Lawrence Lamb serves as the Executive Vice President and Chief Scientific Officer at IN8bio, Inc., where they lead scientific and translational strategy. They completed their PhD with a focus on inflammatory lung disease and macrophage biology, followed by postdoctoral training in molecular evolution, genetic engineering, and transplantation immunology. Dr. Lamb has contributed significantly to the field of immunotherapy for cancer, notably demonstrating the relationship between gamma delta T cell recovery and relapse-free survival in high-risk leukemia patients during their tenure as a Professor of Medicine at the University of Alabama at Birmingham. Their innovative research has garnered support from various governmental and charitable funding sources, culminating in successful IND applications that established IN8Bio.